Open Access Green möglich sobald Postprint bei der ZB eingereicht worden ist.
Cost-of-illness studies of atrial fibrillation: Methodological considerations.
Expert Rev. Pharmacoecon. Outcomes Res. 14, 661-684 (2014)
Atrial fibrillation (AF) is the most common heart rhythm arrhythmia, which has considerable economic consequences. This study aims to identify the current cost-of-illness estimates of AF; a focus was put on describing the studies' methodology. A literature review was conducted. Twenty-eight cost-of-illness studies were identified. Cost-of-illness estimates exist for health insurance members, hospital and primary care populations. In addition, the cost of stroke in AF patients and the costs of post-operative AF were calculated. The methods used were heterogeneous, mostly studies calculated excess costs. The identified annual excess costs varied, even among studies from the USA (∼US$1900 to ∼US$19,000). While pointing toward considerable costs, the cost-of-illness studies' relevance could be improved by focusing on subpopulations and treatment mixes. As possible starting points for subsequent economic studies, the methodology of cost-of-illness studies should be taken into account using methods, allowing stakeholders to find suitable studies and validate estimates.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Times Cited
Scopus
Cited By
Cited By
Altmetric
1.870
0.996
9
8
Anmerkungen
Besondere Publikation
Auf Hompepage verbergern
Publikationstyp
Artikel: Journalartikel
Dokumenttyp
Review
Schlagwörter
Atrial Fibrillation ; Cost-of-illness ; Decision Support Technique ; Health Economics ; Review; 5 European Countries; United-states; Economic-evaluation; Lifetime Risk; Budget Impact; Burden; Care; Population; Prevalence; Predictors
Sprache
englisch
Veröffentlichungsjahr
2014
HGF-Berichtsjahr
2014
ISSN (print) / ISBN
1473-7167
e-ISSN
1744-8379
Quellenangaben
Band: 14,
Heft: 5,
Seiten: 661-684
Verlag
Taylor & Francis
Verlagsort
London
Begutachtungsstatus
Peer reviewed
POF Topic(s)
30202 - Environmental Health
Forschungsfeld(er)
Genetics and Epidemiology
PSP-Element(e)
G-505300-001
PubMed ID
25047664
WOS ID
WOS:000342765500011
Scopus ID
84907060272
Erfassungsdatum
2014-07-24